Debut Plus

₹347

▲ +12.99 +3.89%

As of 09 Sept 2026 · delayed

NSE Listed

T2T

Nureca Limited (NURECA)

Volume: 12,839Avg Vol 1W: 5,827Avg Vol 1M: 8,136.852W Range:₹204₹358
NSE BSE www.nureca.com AI Report
Key Ratios
Checked 5h ago
Market Cap₹319 Cr
Current Price₹347
Previous Close₹334.01
High / Low (52w)₹358 / ₹204
Volume12,839
Avg Vol (1W)5,827
Avg Vol (1M)8,136.8
Stock P/E73.57
Book Value₹189.44
Dividend Yield0%
ROE115.1%
ROA221.2%
Revenue (TTM)₹155 Cr
Revenue Growth19.3%
Profit Margin283.4%
Total Debt₹1 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹4.54
P/B1.75
Debt / Equity0.02
50 DMA₹304.61
200 DMA₹278.12
Day change+3.89%
SurveillanceT2T
Price Chart
₹347▲ 36.45% · 1Y
₹347₹20710.6L
2025-09-10
2026-09-09

20-day avg volume: 8K shares

Pros
  • Healthy return on equity of 115.1%.
  • Company is almost debt-free.
Cons
  • Revenue fell 38% YoY.
  • Stock trades at a high P/E of 74.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹31 Cr₹26 Cr₹32 Cr₹34 Cr₹38 Cr₹40 Cr₹35 Cr₹40 Cr
EBITDA₹0 Cr₹-3 Cr₹3 Cr₹1 Cr₹5 Cr₹5 Cr₹-5 Cr₹5 Cr
Net Profit₹0 Cr₹-3 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹-6 Cr₹3 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹32 Cr₹122 Cr₹34 Cr₹38 Cr₹40 Cr₹35 Cr₹155 Cr₹40 Cr
EBITDA₹2 Cr₹3 Cr₹1 Cr₹5 Cr₹4 Cr₹-6 Cr₹6 Cr₹4 Cr
Net Profit₹2 Cr₹1 Cr₹1 Cr₹3 Cr₹3 Cr₹-7 Cr₹2 Cr₹2 Cr
EPS—0.85————2.11—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹24 Cr₹34 Cr₹186 Cr₹219 Cr₹207 Cr₹205 Cr₹210 Cr₹196 Cr
Total Liabilities₹16 Cr₹19 Cr₹23 Cr₹16 Cr₹12 Cr₹12 Cr₹16 Cr₹15 Cr
Equity₹8 Cr₹15 Cr₹163 Cr₹203 Cr₹195 Cr₹193 Cr₹194 Cr₹181 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-8 Cr₹50 Cr₹19 Cr₹14 Cr₹-4 Cr₹-18 Cr₹3 Cr
Investing₹0 Cr₹0 Cr₹-110 Cr₹-3 Cr₹-16 Cr₹18 Cr₹8 Cr₹14 Cr
Financing₹0 Cr₹8 Cr₹92 Cr₹-7 Cr₹-2 Cr₹-1 Cr₹0 Cr₹-20 Cr
Free Cash Flow₹0 Cr₹-8 Cr₹50 Cr₹19 Cr₹14 Cr₹-4 Cr₹-18 Cr₹3 Cr
Shareholding
Promoter 68.09% Institutions 0.34% Public 31.57%
Efficiency & Working Capital
ROCE3.4%
Interest Coverage4.9
Dividend Payout—
Debtor Days19 d
Inventory Days118 d
Payable Days13 d
Cash Conversion Cycle125 d
Working Capital Days137 d
Shareholding Details

As of 2026-06-30

Promoter68.1%
FII0.1%
DII0.2%
Institutions0.3%
Public31.6%
Promoter Pledge0%
No. of Shareholders33,979
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Jan 2026Jan 2026Mar 2026Jun 2026
Promoters63.2%63.2%63.8%64.1%64.3%64.3%65%65%68.1%68.1%68.1%68.1%
FIIs0.1%0.1%0.7%0.4%1.1%0.1%0.1%0.1%0.1%0.1%0.3%0.1%
DIIs0%0%0%0%0%0%0%0%0%0%0.2%0.2%
Public36.7%36.7%35.5%35.5%34.6%35.6%34.9%34.9%31.8%31.8%31.4%31.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders45,99643,81341,98641,31439,30438,07537,46835,80135,80035,80034,55833,979
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Saurabh GoyalShareholding of Promoter and Promoter Group34.4%32,78,056
Payal GoyalShareholding of Promoter and Promoter Group21.6%20,59,928
Aryan GoyalShareholding of Promoter and Promoter Group12.2%11,59,185
Nectar Biopharma Private LimitedShareholding of Promoter and Promoter Group0%0
Smita GoyalShareholding of Promoter and Promoter Group0%7
Board of Directors
NameDesignationYear
Saurabh GoyalChairman / Executive Director / Managing Director2026
Rajinder SharmaE D & Wholetime Director2026
Ruchita AgarwalIndependent Non Exe. Director2026
Charu SinghIndependent Non Exe. Director2026
V K SharmaIndependent Non Exe. Director2026
Rupinder TewariIndependent Non Exe. Director2026
Kuldip Kumar BhasinIndependent Non Exe. Director2026
Smita GoyalE D & Wholetime Director2026
Nishu KansalCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Home Healthcare and Wellness Produc₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹147 Cr99.9%
Outside India₹0 Cr0.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10111010
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-21Board Meetings—
buyback2025-12-24₹330 max—
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202685005092
202621000021
202664005071
Insider / Designated-Person Trades

25 recent disclosure(s)

SMITA GOYALAcquisition · 200
SMITA GOYALAcquisition · 850
SMITA GOYALAcquisition · 600
SMITA GOYALAcquisition · 6,682
SMITA GOYALAcquisition · 1,657
SMITA GOYALAcquisition · 1,035
Substantial Acquisitions (SAST)

1 disclosure(s)

NULL01/07/2026 · 32,19,113
Company Information
Incorporated2016
ChairmanSaurabh Goyal
AuditorSinghi & Co
Investor Email[email protected]
🌐 www.nureca.com ↗

📍 101 Gala Number Udyog Bhavan, I Flr Sonawala Lane Goregaon(E, Mumbai, Maharashtra, 400063

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Nalwa Sons Investment Ltd.NMDC Steel LimitedNTC Industries Ltd.NTPC Ltd.NTPC Green Energy LimitedNucleus Software Exports Ltd.Nuvama Wealth Management Ltd.Nuvoco Vistas Corporation Ltd.Nexus Select TrustNxt-Infra TrustFSN E-Commerce Ventures Ltd.Oriental Aromatics Ltd.All “N” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search